Trade Summary

6 days ago, Wei Lin, serving as Chief Medical Officer at Revolution Medicines, Inc. (RVMD), sold 2,073 shares at $99.48 per share, for a total transaction value of $206,223.00. Following this transaction, Wei Lin now holds 101,366 shares of RVMD.

This sale represents a 2.00% decrease in Wei Lin's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Revolution Medicines, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.